7MF0
Co-crystal structure of PERK with inhibitor (R)-2-amino-N-cyclopropyl-5-(4-(2-(3,5-difluorophenyl)-2-hydroxyacetamido)-2-methylphenyl)nicotinamide
This is a non-PDB format compatible entry.
Summary for 7MF0
Entry DOI | 10.2210/pdb7mf0/pdb |
Descriptor | Eukaryotic translation initiation factor 2-alpha kinase 3,Eukaryotic translation initiation factor 2-alpha kinase 3, 2-amino-N-cyclopropyl-5-(4-{[(2R)-2-(3,5-difluorophenyl)-2-hydroxyacetyl]amino}-2-methylphenyl)pyridine-3-carboxamide (2 entities in total) |
Functional Keywords | kinase, perk, inhibitor, hc5469, transferase |
Biological source | Homo sapiens (Human) More |
Total number of polymer chains | 1 |
Total formula weight | 37268.82 |
Authors | Wiens, B.,Koszelak-Rosenblum, M.,Surman, M.D.,Zhu, G.,Mulvihill, M.J. (deposition date: 2021-04-08, release date: 2021-05-19, Last modification date: 2023-10-18) |
Primary citation | Calvo, V.,Surguladze, D.,Li, A.H.,Surman, M.D.,Malibhatla, S.,Bandaru, M.,Jonnalagadda, S.K.,Adarasandi, R.,Velmala, M.,Singireddi, D.R.P.,Velpuri, M.,Nareddy, B.R.,Sastry, V.,Mandati, C.,Guguloth, R.,Siddiqui, S.,Patil, B.S.,Chad, E.,Wolfley, J.,Gasparek, J.,Feldman, K.,Betzenhauser, M.,Wiens, B.,Koszelak-Rosenblum, M.,Zhu, G.,Du, H.,Rigby, A.C.,Mulvihill, M.J. Discovery of 2-amino-3-amido-5-aryl-pyridines as highly potent, orally bioavailable, and efficacious PERK kinase inhibitors. Bioorg.Med.Chem.Lett., 43:128058-128058, 2021 Cited by PubMed: 33895276DOI: 10.1016/j.bmcl.2021.128058 PDB entries with the same primary citation |
Experimental method |
Structure validation
Download full validation report